In this podcast our Medical Director, Dr. Brad Lewis, discusses mixing studies- more specifically what a mixing study is and what it isn't, as well as a few quirks we see in some of the mixing studies. Click here ➡️ https://bit.ly/47wN5fN for information on all the different mixing studies that Machaon Diagnostics performs ..read more

In this podcast, our Medical Director, Dr. Brad Lewis, discusses Heparin-Induced Thrombocytopenia, also known as HIT.  Dr. Lewis addresses what HIT is, how to diagnose and interpret testing, and the role of functional testing like the HIPA (Heparin-Induced Platelet Antibody) test ..read more

In this podcast, our Medical Director, Dr. Brad Lewis, talks with Dr. Scott Canna, from the Division of Rheumatology and the Immune Dysregulation Program at Children's Hospital of Philadelphia. Dr. Lewis and Dr. Canna discuss Hemophagocytic lymphohistiocytosis (HLH); what HLH is, treating and diagnosing HLH, and infections that make you particularly worried about the possibility of HLH developing.   Don't forget, Machaon offers genetic testing STAT results in 48 hours ..read more

In this podcast, our Medical Director, Brad Lewis, discusses a  pediatric case of aHUS with Dr. Amara Finch, a Pediatric Resident Physician at the University of Utah. Dr. Finch presents a fascinating case of atypical hemolytic uremic syndrome (aHUS) in a 40-day-old patient. Using Machaon Diagnostics' fast turnaround time, physicians were able to get the results for their aHUS Genetic Panel, saving the patient who was to soon have discontinued care.   Comment from the physician: "We are all very appreciative that we were able to get that test back so quickly. I’m pleased to report th ..read more

..read more

In this podcast, our Medical Director, Brad Lewis, talks with Dr. Christina Klein, a transplant nephrologist and the head of the transplant program at Piedmont Transplant Institute in Atlanta, GA.  Dr. Lewis and Dr. Klein discuss renal transplants and the different roles of testing around renal transplants (i.e. gene sequencing and soluble MAC).  They also discuss the roles of this testing for aHUS and complement activation in patients who are coming in for transplant evaluation. Don't forget... Machaon offers aHUS testing with a turnaround time of 24 hours.  ..read more

In this podcast, our Medical Director, Brad Lewis, continues his conversation with Jamey Kain, Vice President of Genetic Innovation here at Machaon.  Brad and Jamey discuss what next-generation sequencing (NGS) is, why it's important and some of the issues we face with NGS. Don't forget, Machaon offers genetic testing STAT results in 48 hours ..read more

In this podcast, our Medical Director, Brad Lewis, talks with Jamey Kain, Vice President of Genetic Innovation here at Machaon. Brad and Jamey discuss how we design our genetic panels, what goes in, what stays out and how we think about clinical utility and turnaround time considerations. Don't forget, Machaon offers genetic testing STAT results in 48 hours ..read more

In this podcast, our Medical Director, Brad Lewis, talks with Jamey Kain, Vice President of Genetic Innovation here at Machaon. Brad and Jamey discuss how we design our genetic panels, what goes in, what stays out and how we think about clinical utility and turnaround time considerations. Don't forget, Machaon offers genetic testing STAT results in 48 hours ..read more

Our Medical Director, Brad Lewis, addresses a number of questions around hypercoagulability and COVID-19 ..read more